Received Nov 10, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | N/A | 3052834 | IM / LA |
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | 94J5E | IM / LA |
Injection site: severe swelling from shoulder to elbow focused on the Shingrix injection site (lower of the two vaccines), redness, pain, itching. Began one day post vaccination and is still present but lessening on Day 4. Systemic: fever, chills, sweating, fatigue, and nausea from Day 1 to Day 3 post-vaccination.
none
asthma
atorvastatin 10 mg, Wixela inhub 100-50, progesterone 100 mg. estradiol patch 0.025 mg
none
None